 |
|
COMMENTS & OPINIONS
Other Important Aspects of Human T-Lymphotropic Virus 1–Associated Myelopathy
Marco A. Lima, MD, PhD;
Ana C. Leite, MD, PhD;
Marcus T. Silva, MD, PhD;
Abelardo Q. Araújo, MD, PhD
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
We read with great interest the study of Olindo et al1 about the natural history of human T-lymphotropic virus 1 (HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP). The authors followed up a cohort of patients for 14 years and recorded important landmarks in the disease evolution, such as the ability to walk with unilateral or bilateral support, restriction to a wheelchair, and death related to the disease. They also measured the HTLV-1 proviral load in peripheral blood mononuclear cells at time of diagnosis. It was shown that the progression of the motor disability continues throughout the course of disease and that a high HTLV-1 proviral load and an older age at onset adversely affect the outcome. Sex had no influence on the progression of the motor complaints.
However, only the evolution of . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED LETTER
Other Important Aspects of Human T-Lymphotropic Virus 1–Associated Myelopathy—Reply
Stéphane Olindo, Agnès Lézin, and Didier Smadja
Arch Neurol. 2007;64(7):1059-1060.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Natural History of Human T-Lymphotropic Virus 1–Associated Myelopathy: A 14-Year Follow-up Study
Stéphane Olindo, Philippe Cabre, Agnes Lézin, Harold Merle, Martine Saint-Vil, Aissatou Signate, Mickael Bonnan, Aurelie Chalon, Lionel Magnani, Raymond Cesaire, and Didier Smadja
Arch Neurol. 2006;63(11):1560-1566.
ABSTRACT
| FULL TEXT
|
